Recursion Pharmaceuticals director sells shares worth over $108k By Investing.com
Blake Borgeson, a director at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), recently sold 11,447 shares of the company's Class A Common Stock,...
Blake Borgeson, a director at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), recently sold 11,447 shares of the company's Class A Common Stock,...
SlavkoSereda/iStock via Getty Images Crude oil futures climbed more than 1% Thursday as rising worries over geopolitical risk and expectations...
General Mills’ sales forecast has gone as soggy as a bowl of milk-flooded Cheerios, and the packaged goods giant is...
Nike shoes and logo are seen at a store in Nice, France on May 28, 2024.Jakub Porzycki | Nurphoto |...
ZURICH (Reuters) - Switzerland and the United States signed an agreement on Thursday for a mutual exchange of financial account...
Among the early stage startups in Israel's defense sector is wireless sensing company R2 Wireless. The company was founded...
© Copyright 2024 All Rights Reserved